Differences in dose metrics of tumor target and OARs calculated using 3DVH and compass (C-Recal.: Compass Recalculation, C-Recon.: Compass Reconstruction) for the Prostate plans compared with a reference dose calculated using Eclipse TPS.

Inclusion of geometric uncertainties in treatment plan evaluation

van Herk, Marcel
Remeijer, Peter
Lebesque, Joos V.

January 2002

PURPOSE: To correctly evaluate realistic treatment plans in terms of absorbed dose to the clinical t...

The relative differences of D90% of tumor target in MobiusFX and 3DVH compared with the values in the original plan.

Ju-Young Song (3128934)
Jae-Uk Jeong (3128928)
Mee Sun Yoon (3128931)
Sung-Ja Ahn (3128940)
Woong-Ki Chung (3128937)
Taek-Keun Nam (2588158)

August 2017

The relative differences of D90% of tumor target in MobiusFX and 3DVH compared with th...

Analytic vs. Monte Carlo dose calculation comparison.

J. E. Johnson (6336083)
C. Beltran (6336086)
H. Wan Chan Tseung (6336089)
D. W. Mundy (6336092)
J. J. Kruse (6336095)
T. J. Whitaker (6336098)
M. G. Herman (6336101)
K. M. Furutani (6336104)

February 2019

Dose distributions calculated using the analytic TPS algorithm (a) are compared to those calculated ...

Differences in dose metrics of tumor target and OARs calculated using 3DVH and compass (C-Recal.: Compass Recalculation, C-Recon.: Compass Reconstruction) for the Head-Neck plans compared with a reference dose calculated using Eclipse TPS.

Ju-Young Song (3128934)
Sung-Ja Ahn (3128940)

December 2018

Differences in dose metrics of tumor target and OARs calculated using 3DVH and compass (C-Recal.: Co...

Differences in dose metrics of tumor target and OARs calculated using 3DVH and compass (C-Recal.: Compass Recalculation, C-Recon.: Compass Reconstruction) for the Lung plans compared with a reference dose calculated using Eclipse TPS.

Ju-Young Song (3128934)
Sung-Ja Ahn (3128940)

December 2018

Differences in dose metrics of tumor target and OARs calculated using 3DVH and compass (C-Recal.: Co...

Pass rates calculated for the gamma evaluation in the tumor target and OARs compared with a reference TPS dose with the calculated dose in 3DVH and compass (C-Recal.: Compass Recalculation, C-Recon.: Compass Reconstruction) for the Head-Neck plans.

Ju-Young Song (3128934)
Sung-Ja Ahn (3128940)

December 2018

Pass rates calculated for the gamma evaluation in the tumor target and OARs compared with a referenc...

Pass rates calculated for the gamma evaluation in the tumor target and OARs compared with a reference TPS dose with the calculated dose in 3DVH and compass (C-Recal.: Compass Recalculation, C-Recon.: Compass Reconstruction) for the lung plans.

Ju-Young Song (3128934)
Sung-Ja Ahn (3128940)

December 2018

Pass rates calculated for the gamma evaluation in the tumor target and OARs compared with a referenc...

Comparison of the pass rate calculated in a gamma evaluation between a reference dose calculated using Eclipse TPS and a calculated dose using 3DVH and compass.

Ju-Young Song (3128934)
Sung-Ja Ahn (3128940)

December 2018

(A) average pass rate in the tumor target, (B) average pass rate in the OARs.</p

Validation of 3DVH estimated DVH metrics for prostate VMAT plans

Arumugam, Sankar
Xing, Aitang
Young, Tony
Thwaites, David
Holloway, Lois C

January 2015

The accuracy of 3DVH (Sun Nuclear Corporation, USA) reported DVH metrics for target volumes and Orga...

Influence of the contrast agents on treatment planning dose calculations of prostate and rectal cancers

Heydarheydari, Sahel
Farshchian, Negin
Haghparast, Abbas

September 2016

AimThe aim of the present study is to quantify differences in dose calculations caused by using CA a...

An investigation of the dose distribution effect related with collimator angle in volumetric arc therapy of prostate cancer

Bilge, Hatice
Tas, Bora
Ozturk, Sibel Tokdemir

January 2016

To investigate the dose-volume variations of planning target volume (PTV) and organ at risks (OARs) ...

2D versus 3D radiation therapy for prostate carcinoma: A direct comparison of dose volume parameters

Sale, C.
Yeoh, E.
Scutter, S.
Bezak, E.

January 2005

That three dimensional (3D) planning for radiation therapy (RT) of carcinoma of the prostate (CaP) i...

PATIENT-SPECIFIC 3D PRETREATMENT AND POTENTIAL 3D ONLINE DOSE VERIFICATION OF MONTE CARLO-CALCULATED IMRT PROSTATE TREATMENT PLANS

Boggula R
Jahnke L
Wertz H
Lohr F
Wenz F

January 2011

Purpose: Fast and reliable comprehensive quality assurance tools are required to validate the safety...

Dosimetric and radiobiological comparison in different dose calculation grid sizes between Acuros XB and anisotropic analytical algorithm for prostate VMAT.

Kyeong-Hyeon Kim
Jin-Beom Chung
Tae Suk Suh
Sang-Won Kang
Seong-Hee Kang
Keun-Yong Eom
Changhoon Song
In-Ah Kim
Jae-Sung Kim

January 2018

To investigate feasible treatment planning parameters, we aimed to evaluate the dosimetric and radio...

Assessment of delivered rectal dose in prostate cancer radiotherapy

D'aquino, A

November 2021

Prostate radiotherapy gives excellent long-term disease control; however, morbidity from treatment c...

Inclusion of geometric uncertainties in treatment plan evaluation

van Herk, Marcel
Remeijer, Peter
Lebesque, Joos V.

January 2002

PURPOSE: To correctly evaluate realistic treatment plans in terms of absorbed dose to the clinical t...

The relative differences of D90% of tumor target in MobiusFX and 3DVH compared with the values in the original plan.

Ju-Young Song (3128934)
Jae-Uk Jeong (3128928)
Mee Sun Yoon (3128931)
Sung-Ja Ahn (3128940)
Woong-Ki Chung (3128937)
Taek-Keun Nam (2588158)

August 2017

The relative differences of D90% of tumor target in MobiusFX and 3DVH compared with th...

Analytic vs. Monte Carlo dose calculation comparison.

J. E. Johnson (6336083)
C. Beltran (6336086)
H. Wan Chan Tseung (6336089)
D. W. Mundy (6336092)
J. J. Kruse (6336095)
T. J. Whitaker (6336098)
M. G. Herman (6336101)
K. M. Furutani (6336104)

February 2019

Dose distributions calculated using the analytic TPS algorithm (a) are compared to those calculated ...

Differences in dose metrics of tumor target and OARs calculated using 3DVH and compass (C-Recal.: Compass Recalculation, C-Recon.: Compass Reconstruction) for the Head-Neck plans compared with a reference dose calculated using Eclipse TPS.

Ju-Young Song (3128934)
Sung-Ja Ahn (3128940)

December 2018

Differences in dose metrics of tumor target and OARs calculated using 3DVH and compass (C-Recal.: Co...

Differences in dose metrics of tumor target and OARs calculated using 3DVH and compass (C-Recal.: Compass Recalculation, C-Recon.: Compass Reconstruction) for the Lung plans compared with a reference dose calculated using Eclipse TPS.

Ju-Young Song (3128934)
Sung-Ja Ahn (3128940)

December 2018

Differences in dose metrics of tumor target and OARs calculated using 3DVH and compass (C-Recal.: Co...

Pass rates calculated for the gamma evaluation in the tumor target and OARs compared with a reference TPS dose with the calculated dose in 3DVH and compass (C-Recal.: Compass Recalculation, C-Recon.: Compass Reconstruction) for the Head-Neck plans.

Ju-Young Song (3128934)
Sung-Ja Ahn (3128940)

December 2018

Pass rates calculated for the gamma evaluation in the tumor target and OARs compared with a referenc...

Pass rates calculated for the gamma evaluation in the tumor target and OARs compared with a reference TPS dose with the calculated dose in 3DVH and compass (C-Recal.: Compass Recalculation, C-Recon.: Compass Reconstruction) for the lung plans.

Ju-Young Song (3128934)
Sung-Ja Ahn (3128940)

December 2018

Pass rates calculated for the gamma evaluation in the tumor target and OARs compared with a referenc...

Comparison of the pass rate calculated in a gamma evaluation between a reference dose calculated using Eclipse TPS and a calculated dose using 3DVH and compass.

Ju-Young Song (3128934)
Sung-Ja Ahn (3128940)

December 2018

(A) average pass rate in the tumor target, (B) average pass rate in the OARs.</p

Validation of 3DVH estimated DVH metrics for prostate VMAT plans

Arumugam, Sankar
Xing, Aitang
Young, Tony
Thwaites, David
Holloway, Lois C

January 2015

The accuracy of 3DVH (Sun Nuclear Corporation, USA) reported DVH metrics for target volumes and Orga...

Influence of the contrast agents on treatment planning dose calculations of prostate and rectal cancers

Heydarheydari, Sahel
Farshchian, Negin
Haghparast, Abbas

September 2016

AimThe aim of the present study is to quantify differences in dose calculations caused by using CA a...

An investigation of the dose distribution effect related with collimator angle in volumetric arc therapy of prostate cancer

Bilge, Hatice
Tas, Bora
Ozturk, Sibel Tokdemir

January 2016

To investigate the dose-volume variations of planning target volume (PTV) and organ at risks (OARs) ...

2D versus 3D radiation therapy for prostate carcinoma: A direct comparison of dose volume parameters

Sale, C.
Yeoh, E.
Scutter, S.
Bezak, E.

January 2005

That three dimensional (3D) planning for radiation therapy (RT) of carcinoma of the prostate (CaP) i...

PATIENT-SPECIFIC 3D PRETREATMENT AND POTENTIAL 3D ONLINE DOSE VERIFICATION OF MONTE CARLO-CALCULATED IMRT PROSTATE TREATMENT PLANS

Boggula R
Jahnke L
Wertz H
Lohr F
Wenz F

January 2011

Purpose: Fast and reliable comprehensive quality assurance tools are required to validate the safety...

Dosimetric and radiobiological comparison in different dose calculation grid sizes between Acuros XB and anisotropic analytical algorithm for prostate VMAT.

Kyeong-Hyeon Kim
Jin-Beom Chung
Tae Suk Suh
Sang-Won Kang
Seong-Hee Kang
Keun-Yong Eom
Changhoon Song
In-Ah Kim
Jae-Sung Kim

January 2018

To investigate feasible treatment planning parameters, we aimed to evaluate the dosimetric and radio...

Assessment of delivered rectal dose in prostate cancer radiotherapy

D'aquino, A

November 2021

Prostate radiotherapy gives excellent long-term disease control; however, morbidity from treatment c...

Inclusion of geometric uncertainties in treatment plan evaluation

van Herk, Marcel
Remeijer, Peter
Lebesque, Joos V.

January 2002

PURPOSE: To correctly evaluate realistic treatment plans in terms of absorbed dose to the clinical t...

The relative differences of D90% of tumor target in MobiusFX and 3DVH compared with the values in the original plan.

Ju-Young Song (3128934)
Jae-Uk Jeong (3128928)
Mee Sun Yoon (3128931)
Sung-Ja Ahn (3128940)
Woong-Ki Chung (3128937)
Taek-Keun Nam (2588158)

August 2017

The relative differences of D90% of tumor target in MobiusFX and 3DVH compared with th...

Analytic vs. Monte Carlo dose calculation comparison.

J. E. Johnson (6336083)
C. Beltran (6336086)
H. Wan Chan Tseung (6336089)
D. W. Mundy (6336092)
J. J. Kruse (6336095)
T. J. Whitaker (6336098)
M. G. Herman (6336101)
K. M. Furutani (6336104)

February 2019

Dose distributions calculated using the analytic TPS algorithm (a) are compared to those calculated ...

Differences in dose metrics of tumor target and OARs calculated using 3DVH and compass (C-Recal.: Compass Recalculation, C-Recon.: Compass Reconstruction) for the Prostate plans compared with a reference dose calculated using Eclipse TPS.

Abstract

Extracted data

Differences in dose metrics of tumor target and OARs calculated using 3DVH and compass (C-Recal.: Compass Recalculation, C-Recon.: Compass Reconstruction) for the Prostate plans compared with a reference dose calculated using Eclipse TPS.

Abstract

Extracted data

Related items

Related items